Donanemab – one of the first drugs to slow down early-stage Alzheimer’s disease – will not be available on the NHS in ...

Alzheimer’s disease stands as the most widespread form of dementia globally, increasingly burdening families, healthcare systems, and societies as populations age. Although current treatments, ...

A new survey suggests almost 80% of American adults would want to know if they have Alzheimer's disease before they develop ...

Our sense of self is shaped by a small brain region called the precuneus. Now, research suggests that targeting that area may ...

A study has found that individuals with early Alzheimer's disease may have a specific navigational error, which could ...

Millions of older adults take five or more prescription drugs every day to manage chronic illnesses. While polypharmacy is ...

Dr. Charles DeCarli, co-director of the UC Davis Alzheimer’s Research Center, got the news in a call from a colleague March 24.

A 17-year-old has become the world's youngest person ever diagnosed with Alzheimer’s disease, challenging long-standing ...

UVA scientists are calling for clinical trials to see if common HIV drugs could prevent up to 1 million new Alzheimer’s cases ...

People taking drugs for HIV and hepatitis B are less likely to develop Alzheimer’s disease, according to a new study. UVA ...

The slow loss of memory, thinking, and independence that defines Alzheimer’s disease continues to affect millions worldwide.